Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

DISEASE CHARACTERISTICS: * Histologically or cytologically confirmed unresectable primary lung cancer or pulmonary metastases that are unresectable on the basis of technical considerations or are sufficiently numerous that recurrent, potentially inoperable disease is highly probable * Bilateral metastases allowed * Unresectable bronchoalveolar carcinomas allowed * Previously treated primary lung cancer allowed * Disease outside confines of thorax allowed, provided bulk of disease in the chest is clearly the greatest threat to survival and/or extrathoracic disease is controlled * No potentially treatable pulmonary metastases from lymphomas or germ cell tumors * No biopsy proven interstitial fibrosis, radiation induced pneumonitis, or evidence of significant pulmonary hypertension by history, radiologic, echocardiographic, or catheterization studies * No active intracranial or leptomeningeal metastases * Prior resection or radiotherapy for intracranial metastases allowed if the following criteria are met: * No active disease on 2 MRIs done one month apart * No requirement for anticonvulsant medications or steroids * Adequate pulmonary reserve to tolerate pneumonectomy: * Oxygen consumption greater than 50% predicted AND * FEV1 and DLCO greater than 80% predicted OR * FEV1 or DLCO less than 80% predicted allowed if postoperative FEV1 and DLCO is at least 40% predicted on the basis of split function V/Q scan * Prior radiotherapy to chest allowed provide…